Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)

SHE:301096 Revenue

Hangzhou Bio-Sincerity Pharma-Tech had revenue of 160.46M CNY in the quarter ending March 31, 2026, with 24.65% growth. This brings the company's revenue in the last twelve months to 709.72M, down -0.73% year-over-year. In the year 2025, Hangzhou Bio-Sincerity Pharma-Tech had annual revenue of 677.99M, down -15.45%.

• Revenue (ttm): 709.72M
• Revenue Growth: -0.73%
• P/S Ratio: 8.43
• Revenue / Employee: 502.63K
• Employees: 1,412
• Market Cap: 5.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	677.99M	-123.94M	-15.45%
Dec 31, 2024	801.92M	-215.52M	-21.18%
Dec 31, 2023	1.02B	410.04M	67.51%
Jan 1, 2023	607.41M	233.10M	62.27%
Dec 31, 2021	374.31M	167.06M	80.61%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error